Answers are grounded in this paper and cite their sources.
Microvascular free flap reconstruction has become the standard of care for complex head and neck defects, achieving flap survival rates exceeding 90%. Despite this progress, surgical site infections (SSI) remain a major complication with incidence rates from below 10% in low-risk patients to above 40% in previously irradiated cohorts - yet no SSI specific risk stratification framework exists. 537 patients undergoing microvascular head and neck reconstruction were retrospectively analyzed. Multivariate logistic regression identified three independent SSI predictors: Prior radiotherapy, osseous reconstruction and age below 65 years were operationalized into four clinical risk factor groups (I-IV) and characterized against SSI incidence, microbiology and Cox-derived hazard accumulation. Overall SSI incidence was 25.3%. Infection rates escalated stepwise: 12.9% (I), 19.8% (II), 27.3% (III), 50.5% (IV) (p < 0.001). Risk factor group IV showed the highest proportion of patients with gram-negative SSI cultures (24.3% vs. 4.3% in group I; p < 0.001), whereas the pathogen spectrum among culture-positive SSIs did not differ significantly between groups. Three preoperative variables stratify SSI risk across a heterogeneous reconstruction cohort. Risk factor group IV - prior radiotherapy plus at least one further risk factor - identifies a high-risk free flap subgroup in which risk-adapted prophylaxis should be evaluated prospectively.
No takes yet. Share an insight, caveat, or question.
Schuderer et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: